oxazolidin-2-one has been researched along with rifamycins in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Murphy, CK; Osburne, MS; Rothstein, DM | 1 |
Ginsberg, AM | 1 |
Nuermberger, EL; Spigelman, MK; Yew, WW | 1 |
Dartois, V; Dick, T; Gengenbacher, M; Sarathy, J | 1 |
Cole, ST; Dhar, N; Hartkoorn, RC; Lechartier, B; Sala, C; Vocat, A; Zhang, M | 1 |
2 review(s) available for oxazolidin-2-one and rifamycins
Article | Year |
---|---|
Tuberculosis drug development: progress, challenges, and the road ahead.
Topics: Antitubercular Agents; Drug Delivery Systems; Drug Design; Female; Fluoroquinolones; Humans; Male; Mycobacterium tuberculosis; Oxazolidinones; Rifamycins; Tuberculosis | 2010 |
Current development and future prospects in chemotherapy of tuberculosis.
Topics: Adamantane; Animals; Antitubercular Agents; Carbapenems; Clinical Trials as Topic; Diarylquinolines; Drug Delivery Systems; Ethylenediamines; Fluoroquinolones; Humans; Isonicotinic Acids; Mice; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Patient Compliance; Pyrroles; Quinolines; Rifamycins; Tuberculosis, Pulmonary | 2010 |
3 other study(ies) available for oxazolidin-2-one and rifamycins
Article | Year |
---|---|
Enhanced activity of rifalazil in combination with levofloxacin, linezolid, or mupirocin against Staphylococcus aureus in vitro.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Mupirocin; Ofloxacin; Oxazolidinones; Rifamycins; Staphylococcus aureus | 2006 |
Reduced drug uptake in phenotypically resistant nutrient-starved nonreplicating Mycobacterium tuberculosis.
Topics: Acetamides; Antitubercular Agents; Fluoroquinolones; Gene Expression Regulation, Bacterial; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Rifamycins | 2013 |
Bioluminescence for assessing drug potency against nonreplicating Mycobacterium tuberculosis.
Topics: Adamantane; Antitubercular Agents; Colony Count, Microbial; Diarylquinolines; Drug Discovery; Ethylenediamines; Genes, Bacterial; Luminescence; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazines; Oxazolidinones; Photorhabdus; Pyrazinamide; Rifamycins; Xanthenes | 2015 |